These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 15549273)

  • 1. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
    Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy.
    Oh KS; Lee JH; Yi KY; Lim CJ; Lee S; Park CH; Seo HW; Lee BH
    Br J Pharmacol; 2015 May; 172(10):2618-33. PubMed ID: 25597918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
    Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
    Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.
    Bousette N; Hu F; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
    J Mol Cell Cardiol; 2006 Aug; 41(2):285-95. PubMed ID: 16797584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
    Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
    Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases.
    Onan D; Pipolo L; Yang E; Hannan RD; Thomas WG
    Mol Endocrinol; 2004 Sep; 18(9):2344-54. PubMed ID: 15205471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor.
    Liu JC; Chen CH; Chen JJ; Cheng TH
    Mol Pharmacol; 2009 Dec; 76(6):1186-95. PubMed ID: 19755521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts.
    Dai HY; Kang WQ; Wang X; Yu XJ; Li ZH; Tang MX; Xu DL; Li CW; Zhang Y; Ge ZM
    Regul Pept; 2007 Apr; 140(1-2):88-93. PubMed ID: 17188370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.
    Oh KS; Lee JH; Yi KY; Lim CJ; Park BK; Seo HW; Lee BH
    Eur J Pharmacol; 2017 Mar; 799():94-102. PubMed ID: 28163023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
    Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
    J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L; Meng W; Ding J; Cheng M
    Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
    Tandon R; Soni A; Singh RK; Sodhi R; Seth MK; Sinha S; Sahdev S; Dhage G; Das B; Dastidar SG; Shriumalla RK; Yonesu K; Marumoto S; Nagayama T
    Eur J Pharmacol; 2020 Nov; 886():173391. PubMed ID: 32745605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
    Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
    Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
    Zhang YG; Li YG; Liu BG; Wei RH; Wang DM; Tan XR; Bu DF; Pang YZ; Tang CS
    Acta Pharmacol Sin; 2007 Jan; 28(1):36-43. PubMed ID: 17184580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease.
    Bousette N; Pottinger J; Ramli W; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
    Peptides; 2006 Nov; 27(11):2919-26. PubMed ID: 16919371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
    Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
    Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors.
    Herold CL; Behm DJ; Buckley PT; Foley JJ; Wixted WE; Sarau HM; Douglas SA
    Br J Pharmacol; 2003 May; 139(2):203-7. PubMed ID: 12770925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.
    Chiu CZ; Wang BW; Shyu KG
    J Endocrinol; 2014 Mar; 220(3):233-46. PubMed ID: 24481965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.